Search results - 43 results

The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.

in this randomized controlled clinical trial. METHODS:  Thirty infants of Tdap (tetanus, diphtheria, and acellular pertussis)-vaccinated pregnant women and 37 infants of women vaccinated with ...

Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.

context is essential, using well-annotated samples, such as those generated via the Validation of Genotyping Tests- HPV (VALGENT) framework. OBJECTIVE: Our aim was to assess the PapilloCheck HPV assay in ...

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

L; Zhong, N; Zidarn, M; Mercier, J Source: Allergy, Volume 70, Issue 11, p.1372-92 (2015) Keywords: Allergens Biomarkers Clinical Decision-Making Clinical Trials as Topic comorbidity Disease Management ...

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations

Joncourt,F.; Diaz-Manera,J.; Gallardo,E.; A.A. Karaduman; Topaloglu,H.; R. El Sherif; Stringer,A.; Shatillo,A.V.; A.S. Martin; H.L. Peay; Bellgard,M.I.; Kirschner,J.; Flanigan,K.M.; Straub,V.; Bushby,K.; ...

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations.

in clinical trials. Indeed, these vaccines administered to volunteers raise biosafety concerns with respect to human health and the environment that need to be assessed and managed. Health Topics ...

Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.

Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Risk Assessment Vaccination vaccinia virus Viral Vaccines Abstract: The modified vaccinia virus Ankara (MVA) ...

General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.

p.385-94 (2013) Keywords: Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Organisms, Genetically Modified Risk Assessment Vaccination Viruses Abstract: This ...

Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.

at batch release Belgian Change Clinical clinical trial Clinical trials Combination Components Control developing Development distribution EU European future Group Guidelines health Hepatitis Hepatitis ...

An update on vaccines for tuberculosis- there is more to it than just waning of BCG efficacy with time.

Trials, Phase I as Topic Clinical Trials, Phase II as Topic Humans Tuberculosis Tuberculosis Vaccines Abstract: INTRODUCTION: Apart from better diagnostics and new anti-microbial drugs, an effective vaccine ...

QR code

QR code for this page URL